Ulta Beauty (ULTA) Rises on Solid Report

Ulta Beauty (ULTA) joined a short IBD Sector Leaders list on Tuesday as shres of the cosmetics, skin and hair care retailer hold tight following an earnings-inspired jump to new highs, Investor’s Business Daily reported.

The stock gapped up in massive volume on March 11, the day after a better-than-expected quarterly earnings report. In the report, Ulta Beauty said profit for the fiscal fourth quarter that ended in January rose 24% on a 21% increase in revenue. Both figures were in line with the stock’s three-year earnings and sales growth rates.

In the March 10 earnings report, Ulta said sales at stores that have been open at least 14 months have jumped 12.5% due to rising transactions and an increase in average ticket—a measure of how much each customer spends per visit.

Profit for the fiscal year that ends in January is expected to rise 21% to $6.04 a share, followed by a 20% gain the nextyear. Both figures have been revised higher, a bullish sign.

ULTA is up 57% since it was recommended in Cabot Growth Investor in November 2014.

Stock Picks

Loews Corp.

This undervalued stock has strong future earnings growth expectations.


Biogen is the market-share leader in treating multiple sclerosis.


One of Paul Godwin’s favorite stocks in his Cabot Emerging Markets Investor portfolio.

Cabot Wealth Advisory

Does Alibaba (BABA) Stock Measure Up to Amazon (AMZN)?

By Paul Goodwin on September 23, 2016

Alibaba (BABA) is the Amazon (AMZN) of China. But does BABA stock measure up to AMZN stock? Let’s break it down!Read More >

As Stock Market Trends Change, Invest in these New Leaders

By Michael Cintolo on September 22, 2016

History tells us that all stock market trends change, and if you don’t recognize the leaders of that change early, you risk missing out on the next big winners.Read More >

AMZN Stock vs. FB Stock: Which Is the Better Value Buy?

By J. Royden Ward on September 20, 2016

For the past five years, AMZN stock and FB stock have been two of the market's great growth stories. But could you make the case that either stock is still undervalued? Let’s break it down.Read More >